SRZN
SRZN
NASDAQ · Biotechnology

Surrozen Inc

$31.88
-0.76 (-2.33%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -75.1% upside
Low Target $5.53
Average Target $7.94
High Target $9.87
Current Price $31.88
Current
$31.88
Target
$7.94
$5.53 $7.94 avg $9.87
Scenario Analysis
Bear Case
$5.53
-82.7%
Low target
Base Case
$7.94
-75.1%
Avg target
Bull Case
$9.87
+-69.0%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$37.83
-15.7% from high
52-Week Low
$11.39
+179.9% from low
Target vs 52W High
$7.94
-79.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%